CHICAGO, July 31 (Reuters) - Quest Diagnostics (DGX.N), opens new tab on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's disease ...

Advances in drug treatments for Alzheimer’s disease have opened doors for diagnostics, and Quest is the latest to walk through. The clinical testing giant has put forward a blood test designed to help ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. Developed by Fujirebio, the Lumipulse G test measures ...

A Quest Diagnostics Alzheimer's blood test that people could purchase from home without visiting a doctor first is no longer being marketed directly to consumers. The test, known as Quest AD-Detect, ...

Credit: Getty Images. The AD-Detect™ Test for Alzheimer's Disease is a screening test that uses plasma from a single blood draw to evaluate the levels of amyloid beta proteins. A blood-based biomarker ...